In the world of prescription drugs, brand-name manufacturers have employed various strategies to maintain revenue streams in the face of generic competition. One such strategy is the use of “authorized…
The post Understanding the Impact of Authorized G…
A review article in the Journal of Pharmaceutical Sciences analyzes the trends in drug repurposing through the 505(b)(2) pathway, as approved by the USFDA from 2010 to 2020. The study…
The post Review of 505(b)(2) Drug Products Approved by USFDA from 2…
Here’s a summary of a new article that used DrugPatentWatch Data: The article titled “NIH Funding for Patents That Contribute to Market Exclusivity of Drugs Approved 2010–2019 and the Public…
The post DrugPatentWatch reveals NIH funding for patents app…
While answering a question for a DrugPatentWatch user, the question arose of technologies the NIH has licensed. It turns out that they keep a list on their website, so I…
The post List of NIH-Licensed Technologies appeared first on DrugPatentWatch – Ma…
In a recent article published by IAM Magazine, titled “Why Pharma Companies Should File Patents Later In The R&D Process,” Alexander R. Trimble, PhD, a prominent patent attorney, explores the…
The post Filing Strategies for Maximizing Pharma Patents ap…
DrugChatter recently launched as an experimental AI chat-based business intelligence tool. Here’s some of the more interesting questions it’s been asked: Cost savings for bulk lipitor Who Invented Advil? What…
The post DrugChatter Featured Questions ap…
Introducing DrugChatter.com: Empowering Access to Biopharmaceutical Drug Insights through AI Chat We are pleased to introduce DrugChatter.com, a groundbreaking platform that redefines the way professionals obtain concise, cited information on…
The post…
DrugChatter.com: AI Chat for Biopharmaceutical Drug Insights Read Post »
On NPR’s All Things Considered, Sydney Lupkin asked DrugPatentWatch if drug patents could be used to identify injector pens which could then be swapped to fix drug shortages. Referring to…
The post NPR and DrugPatentWatch – Can drug injector pens be sw…
NPR and DrugPatentWatch – Can drug injector pens be swapped? Read Post »
This article was originally published by Jiayi Chen, Zhifeng Zhao, Xinyu Wang and Jingjun Huang in Drug Repurposing – Advances, Scopes and Opportunities in Drug Discovery and is republished here…
The post Utilizing 505(b)(2) Regulatory Pathway for New …
This is a guest post by Oleksandr Topachevskyi at Digital Health Outcomes. Oleksandr may be contacted at [email protected] Commercial, nonprofit, and government companies are quite good at calculating the costs…
The post Social Return on Investment a…